| Brooke Denise Renard, MD | |
|
406 Welch St, Silverton, OR 97381 | |
| (503) 873-8853 | |
| (503) 873-8355 |
| Full Name | Brooke Denise Renard |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 28 Years |
| Location | 406 Welch St, Silverton, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538191085 | NPI | - | NPPES |
| 170108 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD22595 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Santiam Hospital | Stayton, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Santiam Memorial Hospital | 6103729751 | 82 |
News Archive
There are several challenges to be overcome if therapeutic anticancer vaccines, which are designed to boost the patient's anticancer immune response, are to be successfully developed. For example, the viruses used to deliver the tumor protein to the patient's immune system are themselves targeted by the patient's immune system, inducing neutralizing and suppressive responses. But now, a team of researchers, led by Michael Morse, at Duke University Medical Center, Durham, has developed a way to overcome these neutralizing and suppressive responses by using an alphavirus packaged in virus-like replicon particles.
USANA Health Sciences, Inc. today announced record financial results for its fiscal fourth quarter and full-year ended December 29, 2012.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
Today, the FDA issued a warning letter to a company with over 15 million tobacco products listed with the FDA, including many flavored e-liquids, for illegally marketing electronic nicotine delivery system (ENDS) products without authorization.
› Verified 1 days ago
| Entity Name | Santiam Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912178823 PECOS PAC ID: 6103729751 Enrollment ID: O20040130000239 |
News Archive
There are several challenges to be overcome if therapeutic anticancer vaccines, which are designed to boost the patient's anticancer immune response, are to be successfully developed. For example, the viruses used to deliver the tumor protein to the patient's immune system are themselves targeted by the patient's immune system, inducing neutralizing and suppressive responses. But now, a team of researchers, led by Michael Morse, at Duke University Medical Center, Durham, has developed a way to overcome these neutralizing and suppressive responses by using an alphavirus packaged in virus-like replicon particles.
USANA Health Sciences, Inc. today announced record financial results for its fiscal fourth quarter and full-year ended December 29, 2012.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
Today, the FDA issued a warning letter to a company with over 15 million tobacco products listed with the FDA, including many flavored e-liquids, for illegally marketing electronic nicotine delivery system (ENDS) products without authorization.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Denise Renard, MD Po Box 337, Silverton, OR 97381 Ph: (503) 873-8853 | Brooke Denise Renard, MD 406 Welch St, Silverton, OR 97381 Ph: (503) 873-8853 |
News Archive
There are several challenges to be overcome if therapeutic anticancer vaccines, which are designed to boost the patient's anticancer immune response, are to be successfully developed. For example, the viruses used to deliver the tumor protein to the patient's immune system are themselves targeted by the patient's immune system, inducing neutralizing and suppressive responses. But now, a team of researchers, led by Michael Morse, at Duke University Medical Center, Durham, has developed a way to overcome these neutralizing and suppressive responses by using an alphavirus packaged in virus-like replicon particles.
USANA Health Sciences, Inc. today announced record financial results for its fiscal fourth quarter and full-year ended December 29, 2012.
HalioDx, an immuno-oncology company pioneering the immunological diagnosis of cancers, announces the availability of Brightplex, a novel high capacity IHC multiplex technology enabling multiple biomarkers to be analyzed on a single FFPE slide.
Ligand Pharmaceuticals Incorporated announced today that it has received $2 million in milestone payments from N. V. Organon, a subsidiary of Merck & Co., Inc., stemming from its research collaboration that is due to expire at the end of December.
Today, the FDA issued a warning letter to a company with over 15 million tobacco products listed with the FDA, including many flavored e-liquids, for illegally marketing electronic nicotine delivery system (ENDS) products without authorization.
› Verified 1 days ago
John P Yang, M.D Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Glenn Ira Bernstein, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Dr. Mark Calvin Rowley, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 607 Welch Street, Silverton, OR 97381 Phone: 503-873-7920 Fax: 503-873-7340 | |
Denis Jon Dalisky, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 | |
Dr. Amy Nicole Zastrow, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-364-3787 | |
Dr. Barbara Linn Keller, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 406 Welch St, Silverton, OR 97381 Phone: 503-873-8853 Fax: 503-873-8355 |